Aspire Biopharma Holdings (ASBP) Inventory Average (2025 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Inventory Average of $311567.0 for Q1 2026, up 115.92% quarter-over-quarter from $144298.5 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Inventory Average (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Inventory Average for 2 consecutive years, with $311567.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 8.29 Mn | -3.87 Mn | -30,086.00 | 329,212.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 329,212.00 |
| Mar 31, 2026 | 311,567.00 |
| Dec 31, 2025 | 144,298.50 |